Jubilant Ingrevia commissions new acetic anhydride plant at Bharuch, Gujarat
This plant adds around 60,000 MT of capacity, whereby scaling Jubilant Ingrevia’s overall annual Acetic Anhydride capacity to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Multiple sclerosis market to generate sales of $29.8 bn by 2030: GlobalData
Tolebrutinib is expected to be the leading BTK inhibitor by 2030, with forecasted sales of approximately $2.6B across the 7MM
Dr Reddy’s ropes in Sonu Sood as brand ambassador for Rebalanz VITORS
Rebalanz VITORS is a ready-to-serve fruit beverage with essential electrolytes and minerals to help replenish essential salts in…
Sanofi Soliqua to face fierce competition in Indian T2D insulin market: GlobalData
As branded insulins become available in India, they will face fierce competition from the existing insulins and upcoming…
Dimensions HRD Consultants acquires Qwazent Talent Solutions
The acquisition of Qwazent will enable Dimensions to expand its footprint in the pharma and healthcare industry
Merck acquires Prometheus Biosciences
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and…
Bugworks Research to present eight posters at ECCMID 2023 in Denmark
The eight posters highlight data from the microbiological and efficacy studies of the clinical candidate, BWC0977 that exhibits…
Finance and Health Minister of Telangana inaugurates Aurobindo Oncology Block in Hyderabad
The Aurobindo Oncology Block for MNJ Hospital, a 300-bed facility, will help in offering free cancer treatment for the…
Nutrify C Suite Summit 2023 to be held this June in Mumbai
The two-day Nutrify C Suite Summit 2023 seeks to be bigger and better with the convergence of decision makers and KOLs from…
Companies must be more transparency about their ESG strategies: GlobalData
GlobalData’s ESG Sentiment Polls Q4 2022 find that 68 per cent of respondents either believed that their company did not have an…
Riad Mishlawi named as next CEO of Hikma Pharma
Mishlawi was instrumental in the growth and global expansion of the group's injectables business into a market-leading position
SII restarts manufacturing of COVISHIELD
Adar Poonawalla informs that the company already has six million booster doses of Covovax vaccine available and adults must take…
Synthetic lipids: Paving the path for better drug delivery systems
Arun Kedia, MD, VAV Lipids informs that as seen in the new mRNA-based COVID-19 vaccine delivery systems, synthetic lipid…
Business strategy and forecasting: How generics pharma can befriend them?
Sanobar Syed, Associate Director, Beigene explains how and why pharma companies need to leverage forecasting and business…
Lupin Diagnostics launches Regional Reference Laboratory in Bengaluru
After establishing presence in Hyderabad, this launch expands footprint in South India
Stability of input costs, specialty product launches to support performance of Indian pharma…
Revenues of ICRA’s sample set expected to grow by 6-8 per cent in FY2023 and FY2024; operating profit margins to stabilise at…
Generic drug development: The way forward
Anantha Keerthi, Partner, Vector Consulting Group, points out that pharma companies need to either launch many new speciality…
Decentralised clinical trials software in 2023: What to expect
Rajesh Pothula, Product Marketing Manager, Clinion informs that decentralised clinical trials software market will witness trends…
Recent developments threaten COVID-19 vaccine demand and revenues: GlobalData
SAGE no longer recommends annual COVID-19 vaccine boosters for healthy adults under 60 years of age after they have received both…
Merck, Eisai to discontinue late-stage study for skin cancer
Improvement in overall survival was one of the study's dual main goals, according to Merck and Eisai